- Home
- ALTI vs ALDX Comparison
ALTI vs ALDX Comparison
Compare ALTI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- ALDX
- Stock Information
- Founded
- ALTI 2020
- ALDX 2004
- Country
- ALTI United States
- ALDX United States
- Employees
- ALTI N/A
- ALDX N/A
- Industry
- ALTI Investment Managers
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTI Finance
- ALDX Health Care
- Exchange
- ALTI Nasdaq
- ALDX Nasdaq
- Market Cap
- ALTI 302.7M
- ALDX 133.7M
- IPO Year
- ALTI N/A
- ALDX 2014
- Fundamental
- Price
- ALTI $3.29
- ALDX $2.16
- Analyst Decision
- ALTI
- ALDX Strong Buy
- Analyst Count
- ALTI 0
- ALDX 2
- Target Price
- ALTI N/A
- ALDX $9.50
- AVG Volume (30 Days)
- ALTI 73.4K
- ALDX 1.5M
- Earning Date
- ALTI 05-12-2025
- ALDX 05-20-2025
- Dividend Yield
- ALTI N/A
- ALDX N/A
- EPS Growth
- ALTI N/A
- ALDX N/A
- EPS
- ALTI N/A
- ALDX N/A
- Revenue
- ALTI $206,935,000.00
- ALDX N/A
- Revenue This Year
- ALTI $24.86
- ALDX N/A
- Revenue Next Year
- ALTI $10.74
- ALDX N/A
- P/E Ratio
- ALTI N/A
- ALDX N/A
- Revenue Growth
- ALTI N/A
- ALDX N/A
- 52 Week Low
- ALTI $2.33
- ALDX $1.14
- 52 Week High
- ALTI $5.45
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- ALTI 54.28
- ALDX 34.82
- Support Level
- ALTI $3.18
- ALDX $1.90
- Resistance Level
- ALTI $3.50
- ALDX $2.89
- Average True Range (ATR)
- ALTI 0.18
- ALDX 0.23
- MACD
- ALTI -0.01
- ALDX 0.10
- Stochastic Oscillator
- ALTI 47.50
- ALDX 26.26
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.